These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3026536)

  • 21. The influence of nifedipine and verapamil on the ischaemia-induced changes in canine sarcolemmal membranes.
    Kobusiewicz W; Ogonowska-Kobusiewicz M; Michalak J; Ledwozyw A
    Arch Vet Pol; 1995; 35(1-2):79-87. PubMed ID: 9071455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyproheptadine on [3H]-d-cis-diltiazem binding sites in cardiac sarcolemmal membranes of rats.
    Xin HB; Zhang BH; Liu YW
    Yao Xue Xue Bao; 1994; 29(9):641-6. PubMed ID: 7900533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
    Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
    J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant activity of calcium channel blocking drugs.
    Mak IT; Weglicki WB
    Methods Enzymol; 1994; 234():620-30. PubMed ID: 7808338
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
    Warltier DC; Meils CM; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):296-302. PubMed ID: 7248040
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the calcium entry blocker receptor complex in cardiac sarcolemmal membrane vesicles.
    Kaczorowski GJ; Garcia ML; King VF
    Prog Clin Biol Res; 1988; 252():29-34. PubMed ID: 2450371
    [No Abstract]   [Full Text] [Related]  

  • 28. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
    Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
    Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for down-regulation of 3H-nitrendipine recognition sites in mouse brain after long-term treatment with nifedipine or verapamil.
    Panza G; Grebb JA; Sanna E; Wright AG; Hanbauer I
    Neuropharmacology; 1985 Nov; 24(11):1113-7. PubMed ID: 3001573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of calcium ion antagonists in myocardial ischemia.
    Nayler WG
    Clin Invest Med; 1980; 3(1-2):91-9. PubMed ID: 7471544
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of anipamil on myocardial sarcolemmal and mitochondrial calcium transport, comparison with verapamil and nifedipine.
    Ferrari R; Boraso A; Cargnoni A; Pasini E; Raddino R; Albertini A
    Eur J Pharmacol; 1990 Sep; 189(2-3):149-61. PubMed ID: 2147656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles].
    Raddino R; Poli E; Manca C; Ceconi C; Ferrari R
    Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific binding of [3H]d-cis-diltiazem to cardiac sarcolemma and its inhibition by calcium.
    Balwierczak JL; Schwartz A
    Eur J Pharmacol; 1985 Oct; 116(1-2):193-4. PubMed ID: 2932342
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
    Kates RA; Zaggy AP; Norfleet EA; Heath KR
    Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of verapamil, diltiazem and nifedipine on baroreceptor reflexes.
    Zsotér TT; Nebitko RL; Chow R
    Clin Invest Med; 1988 Dec; 11(6):430-4. PubMed ID: 3229038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effect of calcium slow channel blockers (verapamil, nifedipine and diltiazem) in ventricular arrhythmias induced by coronary artery occlusion in dogs.
    Kaur AH; Singh M; Singh J
    Indian J Exp Biol; 1986 May; 24(5):287-91. PubMed ID: 3770817
    [No Abstract]   [Full Text] [Related]  

  • 40. Low affinity binding sites for 1,4-dihydropyridines in mitochondria and in guinea pig ventricular membranes.
    Brush KL; Perez M; Hawkes MJ; Pratt DR; Hamilton SL
    Biochem Pharmacol; 1987 Dec; 36(23):4153-61. PubMed ID: 2825717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.